Please ensure that you have reviewed the instructions below and prepare your abstract accordingly prior to submission.

Abstracts are to be submitted via the abstract portal.

You are invited to submit an abstract/s as one of the following presentation types:

• Oral Presentation
• Poster (one single A0 size page printed in portrait format, poster must not exceed 841mm wide x 1189mm high)  

Abstracts are invited for submission in the following themes: 

• Risk factors (diet, obesity, microbiome, exercise, genetics, cardiometabolic and others)
• Public Health and Epidemiology
• New therapies (devices, pharmacological, non- pharmacological)
• Complications of Hypertension (stoke, kidney disease, heart failure, aortic aneurysm and others)
• Clinical trials and blood pressure measurement
• Mechanisms of hypertension (physiological, RAAS, molecular, immune, molecular biology and others)
• Comorbidities
• Pulmonary Hypertension
• Other

Abstracts are to be submitted via the abstract portal. Presentation title, author names or affiliations and abstract to be typed directly into the text box provided within the online submission portal.

When submitting your abstract please ensure you follow the below formatting guidelines: 

• Abstract should be no more than 350 words. Title, authors and affiliations are not included in the word count.
• Abstract should be formatted under subheadings of Background and Aim, Methods, Results, Conclusions.
• No figures or tables are not allowed.
• All text should be entered in sentence case (do not type in CAPITAL LETTERS). 
• Abstracts should be thoroughly checked for spelling and grammar, as if successful, will be included in the book of abstracts. 

• Only abstracts submitted via the online abstract submission portal will be considered for the 2026 program. The submission portal is now open and closes at 23:59pm Friday 28 August 2026 Australian Eastern Standard Time (AEST).

  Once an abstract has been submitted via the online submission portal, an acknowledgement email will be sent to the submitting author. If this email is not received, please first check the spam folder, then contact the conference organiser via email  hypertensionaus@expertevents.com.au

  The presenting author/s of all accepted abstracts must register and pay the applicable registration fee by Monday 28 September 2026. If registration isn’t completed by this date, the organising committee reserve the right to remove the presentation from the program.

All submitted abstracts will be blind reviewed by at least three reviewers.

In evaluating each abstract, reviewers will be unaware of authors or institutions involved with the work described in the abstract. (Abstracts will be suitably anonymised by the program committee before being sent out to reviewers).

The reviewers will assign accepted abstracts either to oral or poster presentation.

Notification of the outcome of the review and acceptances will be sent to the contact person (this should be the first presenting author) in late September 2026.

Only the contact person will be notified of acceptance or non- acceptance, and it is their responsibility to notify all other authors about the outcome of the reviewers’ decision.

For all accepted abstracts, further details regarding the oral presentation (PowerPoint presentation) and poster presentation (poster size, format, style and layout etc) will be communicated to the contact person as appropriate.

The duration of each oral presentation will be determined by the committee.

Only HA members are eligible for ASM awards

All presenting authors (maximum of two) must be registered for the conference to be able to present the abstract. The deadline for registration is Monday 28 September 2026.

Accepted abstracts will be published in the conference program only if the presenting author has registered for the ASM.

Enquiries regarding abstracts should be emailed to hypertensionaus@expertevents.com.au.